Targeting Difficult Protein-Protein Interactions with Plain and General Computational Approaches

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Chemical Biology

Background:

• Protein-protein interactions (PPIs) are crucial for cell signaling in health and disease.
• The complexity of PPIs presents challenges for drug development, limiting the druggability of interacting proteins.
• Molecular Dynamics (MD) offers a robust method to study protein surface changes during interactions.

Purpose of the Study:

• To review successful applications of MD-based methods for predicting PPI interfaces of pharmaceutical relevance.
• To demonstrate how combining structural, dynamic, and energetic data can guide drug design.
• To highlight the potential of targeting key PPIs in cancer and infectious diseases.

Main Methods:

• Utilizing MD simulations to analyze protein-interacting surfaces.
• Integrating structural, dynamic, and energetic data from simulations.
• Complementing computational predictions with experimental validation.

Main Results:

• Successful prediction of interfacial areas in pharmaceutically important PPIs.
• Development of efficient strategies combining MD data and experiments.
• Identification of small molecules with potential therapeutic activities.

Conclusions:

• MD-based strategies are effective for predicting PPI targets and designing novel therapeutics.
• Targeting specific PPIs in angiogenic pathways and antigen-antibody recognition holds promise for drug discovery.
• This approach advances drug discovery and chemical biology by enabling the targeting of challenging PPIs.